Assignee
QYUNS THERAPEUTICS CO LTD
CN·6 granted patents·3 pending applications·0 citations·filing 2016–2025
Top patents by PatentIndex Score
9 records- 0172US2026098101A1Anti-human interleukin 36 receptor monoclonal antibody and use thereofQYUNS THERAPEUTICS CO LTD·Filed 2025·Application pending·0 cites
- 0268US12552870B2Anti-human interleukin 36 receptor monoclonal antibody and methods of use thereof to treat diseaseQYUNS THERAPEUTICS CO LTD·Filed 2025·Granted Feb 17, 2026·0 cites·12 claims
- 0361US12378309B2Anti-human thymic stromal lymphopoietin (TSLP) monoclonal antibody and use thereof to treat diseaseQYUNS THERAPEUTICS CO LTD·Filed 2024·Granted Aug 5, 2025·0 cites·6 claims
- 0461US12351626B2Anti-human interleukin-33 monoclonal antibody and use thereofQYUNS THERAPEUTICS CO LTD·Filed 2024·Granted Jul 8, 2025·0 cites·7 claims
- 0561US10796787B2Method for identifying antigen-specific T cell receptors in primateQYUNS THERAPEUTICS CO LTD·Filed 2018·Granted Oct 6, 2020·0 cites·12 claims
- 0653US2024254244A1ANTI-HUMAN INTERFERON a RECEPTOR 1 MONOCLONAL ANTIBODY AND APPLICATION THEREOFQYUNS THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0752US10042975B2Method for identifying antigen-specific antibodies in primateQYUNS THERAPEUTICS CO LTD·Filed 2016·Granted Aug 7, 2018·0 cites·13 claims
- 0850US2024083994A1Cell strain for producing biosimilar drug of ustekinumab and production method thereforQYUNS THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0946US12297280B2Monoclonal antibodies against human interleukin-4 receptor alpha, encoding nucleic acids thereof and method of use thereof to treat IL-4 or IL-4/IL-13-mediated diseasesQYUNS THERAPEUTICS CO LTD·Filed 2019·Granted May 13, 2025·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when QYUNS THERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →